Exploring per-base quality scores as a surrogate marker of cell-free DNA fragmentome.
Per-base quality scores are widely treated as technical metadata in next-generation sequencing. These results provide initial evidence that quality scores could serve as a low-cost, alignment-free surrogate signal for cfDNA-based cancer detection.
Per-base quality scores are widely treated as technical metadata in next-generation sequencing. These results provide initial evidence that quality scores could serve as a low-cost, alignment-free surrogate signal for cfDNA-based cancer detection.
What the study was
- Study design
- Not specified
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Briefings in bioinformatics
Why it surfaced
Low-signal Early cancer detection entry (Not specified design); retained for topic coverage completeness.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.